Hang Chen
陈航
Hang Chen is a serial entrepreneur who has co-founded two distinct AI companies. He first emerged as co-founder and CEO of Neox Biotech (星亢原), a Beijing-based drug-discovery startup founded in 2018 that applied AI, biophysics and high-throughput experimentation to design biologic drugs and PROTAC degraders — described in a 2022 5Y Capital piece as China's first company to focus on AI-driven macromolecular drug development . More recently, as of 2025-2026 coverage by Yunqi Capital, he is co-founder and CEO of Manycore Tech (群核科技), a spatial-intelligence company positioning itself as the "pick-and-shovel" infrastructure layer for 3D AI applications; the firm filed for a Hong Kong IPO in early 2026 . 5Y Capital backed his first venture , while Yunqi Capital has featured his second.
AI-generated — may contain errors, please verify.
Coverage
Yunqi Capital Portfolio Company Manycore Tech Lists on Hong Kong Stock Exchange: From First Institutional Investment to the IPO Bell
13 Years Alongside a Peer, Witnessing the Birth of "The World's First Spatial Intelligence Stock"
云启资本·A Conversation with Manycore's Huang Xiaohuang: Fifteen Years as a Founder, Still a Youngster at Heart
A story about trust, growth, and mutual success.
线性资本·After 13 Years, Manycore Tech Clears Hong Kong Stock Exchange Listing Hearing | Qixing Chronicles
Set to become the "world's first publicly traded spatial intelligence company"
云启资本·Three "Tech Guys" Valentine's Day Gift: Early-Stage Portfolio Company Manycore Tech Completes Filing for Hong Kong IPO | Yunqi Capital
Race to become the "first global spatial intelligence stock"
云启资本·The "Pick-and-Shovel" Play for Spatial Intelligence: Manycore Tech Opens Its Spatial Foundation Layer to All | Yunqi Capital
Being the "Pick-and-Shovel Play" for the Spatial Intelligence Era
云启资本·Manycore Tech CEO Hang Chen: When Chinese AI Meets the Global Market — Manycore Tech's Overseas Expansion | Yunqi Capital Doers Series
At a time when "going global" has become a core growth strategy for tech companies, challenges like **"overseas launch," "localization,"** and **"sustainable growth"** strike directly at the pain points of business expansion.
云启资本·Leaving NVIDIA in 2011: A Straight-Shooting Technologist's 14 Years of Entrepreneurial Reflections | Linear Voice
Innovation is, at times, like a genetic mutation of human intellect.
线性资本·July: Seeking Vast Possibilities | 5Y News Monthly
The big news from last month.
五源资本·From Tech to Business: New Possibilities Brought by ITBT | 5Y Talk
We spoke with five entrepreneurs about their progress and breakthroughs.
五源资本·5Y News | Neox Biotech Completes Tens of Millions of Dollars in Series A+ Funding to Advance Innovative Drug Pipeline
5Y Capital continues to provide support.
五源资本·5Y Talk | How Can Computing and AI Break Through the Traditional Paradigm of Drug Discovery?
Entering the Game, Direction, and the Future.
五源资本·5Y News｜Neox Biotech Completes $30 Million Series A Round, 5Y Capital Continues Support
Exploring the most cutting-edge drug modalities.
五源资本·5Y Capital's Xutian Jing: ITBT Sector Has a Promising Future, Poised to Produce a New Breed of Pharma Companies with Strong Cash-Generation Capabilities | Light View
ITBT is a long game, but when it succeeds, its contribution to human society is immense.
五源资本·
